Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hbp1
|
ENSMUSG00000002996.11 | high mobility group box transcription factor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_31983333_31983529 | Hbp1 | 32896 | 0.155534 | 0.77 | 6.1e-12 | Click! |
chr12_31983866_31984026 | Hbp1 | 33411 | 0.154309 | 0.67 | 1.7e-08 | Click! |
chr12_31993262_31993413 | Hbp1 | 42802 | 0.131802 | 0.59 | 2.2e-06 | Click! |
chr12_31998789_31998981 | Hbp1 | 48350 | 0.118897 | 0.53 | 3.7e-05 | Click! |
chr12_31949770_31950168 | Hbp1 | 201 | 0.945711 | 0.44 | 7.1e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr18_20616739_20617639 | 159.21 |
Gm16090 |
predicted gene 16090 |
48071 |
0.1 |
chr18_20621651_20622570 | 140.99 |
Gm16090 |
predicted gene 16090 |
43150 |
0.11 |
chr18_20625060_20625736 | 81.72 |
Gm16090 |
predicted gene 16090 |
39862 |
0.12 |
chr12_3236518_3237725 | 54.06 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr17_13654565_13655321 | 49.89 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
13948 |
0.15 |
chr9_37027933_37028106 | 38.86 |
n-R5s82 |
nuclear encoded rRNA 5S 82 |
1620 |
0.34 |
chr18_20625915_20626381 | 38.62 |
Gm16090 |
predicted gene 16090 |
39112 |
0.12 |
chr10_38553365_38553786 | 36.59 |
Gm22911 |
predicted gene, 22911 |
61906 |
0.14 |
chr13_83880301_83880686 | 35.93 |
2810049E08Rik |
RIKEN cDNA 2810049E08 gene |
10715 |
0.21 |
chr15_10655238_10655729 | 35.87 |
Gm10389 |
predicted gene 10389 |
55146 |
0.1 |
chr6_36755081_36755527 | 34.31 |
Ptn |
pleiotrophin |
54875 |
0.13 |
chr14_118230141_118230337 | 31.73 |
Gm4675 |
predicted gene 4675 |
5993 |
0.14 |
chr9_102235369_102235971 | 31.36 |
Gm37260 |
predicted gene, 37260 |
38066 |
0.14 |
chr7_101523234_101523570 | 30.03 |
Gm35363 |
predicted gene, 35363 |
14928 |
0.13 |
chr1_41605098_41605443 | 29.77 |
Gm28634 |
predicted gene 28634 |
75727 |
0.12 |
chr15_85464224_85464612 | 29.49 |
7530416G11Rik |
RIKEN cDNA 7530416G11 gene |
38809 |
0.14 |
chr5_42777207_42777429 | 28.89 |
Gm5554 |
predicted gene 5554 |
187291 |
0.03 |
chr4_85707330_85707812 | 28.64 |
Adamtsl1 |
ADAMTS-like 1 |
193244 |
0.03 |
chr18_20615543_20616002 | 28.06 |
Gm16090 |
predicted gene 16090 |
49488 |
0.1 |
chr17_9580072_9580515 | 27.73 |
Gm49807 |
predicted gene, 49807 |
30602 |
0.2 |
chr1_96346717_96347057 | 27.11 |
Gm37076 |
predicted gene, 37076 |
33645 |
0.18 |
chr12_29526481_29526772 | 26.57 |
Myt1l |
myelin transcription factor 1-like |
1758 |
0.41 |
chr14_93083221_93083444 | 26.53 |
Gm23509 |
predicted gene, 23509 |
54857 |
0.15 |
chr15_67245652_67245820 | 26.53 |
1700012I11Rik |
RIKEN cDNA 1700012I11 gene |
18967 |
0.26 |
chr13_84752343_84752734 | 26.07 |
Gm26913 |
predicted gene, 26913 |
61597 |
0.15 |
chr12_49945819_49946221 | 25.86 |
Gm7481 |
predicted gene 7481 |
104269 |
0.08 |
chr16_64069361_64069662 | 25.77 |
Gm49627 |
predicted gene, 49627 |
114381 |
0.07 |
chr1_79450325_79450959 | 25.63 |
Scg2 |
secretogranin II |
10522 |
0.24 |
chr5_107497460_107497812 | 25.50 |
Btbd8 |
BTB (POZ) domain containing 8 |
140 |
0.93 |
chr13_59092007_59092498 | 25.49 |
4930415C11Rik |
RIKEN cDNA 4930415C11 gene |
8159 |
0.17 |
chr15_13392917_13393530 | 25.26 |
Gm8238 |
predicted gene 8238 |
25633 |
0.22 |
chr5_75013200_75013361 | 25.24 |
Gm42576 |
predicted gene 42576 |
9801 |
0.14 |
chr8_94995735_94996350 | 25.08 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
381 |
0.78 |
chr3_137683186_137683769 | 24.62 |
Gm42610 |
predicted gene 42610 |
7510 |
0.14 |
chr7_4130711_4131434 | 24.13 |
Ttyh1 |
tweety family member 1 |
65 |
0.94 |
chr18_45896851_45897467 | 24.10 |
A330093E20Rik |
RIKEN cDNA A330093E20 gene |
650 |
0.79 |
chr2_101172759_101173110 | 24.07 |
Gm20693 |
predicted gene 20693 |
397690 |
0.01 |
chr12_38303946_38304117 | 24.01 |
Gm18338 |
predicted gene, 18338 |
65199 |
0.14 |
chr9_77502495_77502690 | 23.75 |
Lrrc1 |
leucine rich repeat containing 1 |
29852 |
0.14 |
chr16_64069102_64069325 | 23.60 |
Gm49627 |
predicted gene, 49627 |
114083 |
0.07 |
chr14_12393556_12393971 | 23.32 |
Gm48267 |
predicted gene, 48267 |
8467 |
0.14 |
chr8_6132218_6132692 | 23.23 |
Gm44842 |
predicted gene 44842 |
86213 |
0.09 |
chr2_62807459_62807865 | 23.12 |
Gm13569 |
predicted gene 13569 |
1525 |
0.44 |
chr1_18758436_18758855 | 22.60 |
Gm5252 |
predicted gene 5252 |
50217 |
0.18 |
chr8_54864790_54864964 | 22.52 |
n-R5s98 |
nuclear encoded rRNA 5S 98 |
1384 |
0.45 |
chr12_46075749_46076236 | 22.42 |
Gm24948 |
predicted gene, 24948 |
91649 |
0.09 |
chr1_66177864_66178060 | 22.25 |
Map2 |
microtubule-associated protein 2 |
2412 |
0.38 |
chr13_36724536_36725119 | 22.10 |
Gm30177 |
predicted gene, 30177 |
2431 |
0.23 |
chr2_25125625_25126488 | 22.04 |
AL732309.1 |
exonuclease 3'-5' domain containing 3 (EXD3) pseudogene |
9775 |
0.08 |
chr14_100374770_100375216 | 22.03 |
Gm26367 |
predicted gene, 26367 |
43490 |
0.15 |
chr3_40070102_40070729 | 21.98 |
Gm42785 |
predicted gene 42785 |
246838 |
0.02 |
chr14_14349938_14350878 | 21.87 |
Il3ra |
interleukin 3 receptor, alpha chain |
787 |
0.48 |
chr1_53740102_53740664 | 21.84 |
Stk17b |
serine/threonine kinase 17b (apoptosis-inducing) |
22310 |
0.18 |
chr6_115123316_115123739 | 21.80 |
Gm17733 |
predicted gene, 17733 |
11308 |
0.13 |
chr13_13820325_13820514 | 21.68 |
Gng4 |
guanine nucleotide binding protein (G protein), gamma 4 |
1140 |
0.45 |
chr8_69160881_69161314 | 21.47 |
Lzts1 |
leucine zipper, putative tumor suppressor 1 |
20144 |
0.15 |
chr11_31847247_31847418 | 21.32 |
Gm12107 |
predicted gene 12107 |
14672 |
0.18 |
chr17_7700834_7701025 | 21.31 |
Gm25872 |
predicted gene, 25872 |
3911 |
0.27 |
chr2_79351345_79351496 | 21.27 |
Gm22606 |
predicted gene, 22606 |
3055 |
0.24 |
chr14_119513370_119513775 | 21.20 |
Gm6212 |
predicted gene 6212 |
130440 |
0.05 |
chr18_16703519_16704021 | 21.14 |
Gm15485 |
predicted gene 15485 |
24963 |
0.21 |
chr13_85068402_85068695 | 21.07 |
Gm47745 |
predicted gene, 47745 |
25787 |
0.17 |
chr13_15543962_15544319 | 21.06 |
Gli3 |
GLI-Kruppel family member GLI3 |
80160 |
0.08 |
chr3_8866082_8866744 | 21.06 |
Gm15467 |
predicted gene 15467 |
14786 |
0.17 |
chr5_32713265_32714499 | 20.99 |
Gm43852 |
predicted gene 43852 |
106 |
0.94 |
chr8_32959326_32959711 | 20.93 |
Gm3985 |
predicted gene 3985 |
9492 |
0.28 |
chr10_92556339_92556524 | 20.89 |
Gm4800 |
predicted gene 4800 |
12761 |
0.16 |
chr18_30509304_30509455 | 20.89 |
Gm7936 |
predicted pseudogene 7936 |
14006 |
0.19 |
chr11_32158171_32158538 | 20.83 |
Gm12109 |
predicted gene 12109 |
26651 |
0.12 |
chr7_73917720_73918558 | 20.82 |
Gm45003 |
predicted gene 45003 |
29395 |
0.14 |
chr3_17788774_17789074 | 20.79 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
997 |
0.54 |
chr19_18873794_18873972 | 20.71 |
Trpm6 |
transient receptor potential cation channel, subfamily M, member 6 |
33246 |
0.21 |
chr5_133938081_133938296 | 20.55 |
Gm2404 |
predicted gene 2404 |
18186 |
0.23 |
chr13_84752106_84752283 | 20.54 |
Gm26913 |
predicted gene, 26913 |
61253 |
0.15 |
chr16_91140532_91140860 | 20.46 |
Gm49612 |
predicted gene, 49612 |
5220 |
0.12 |
chr3_145890165_145890867 | 20.38 |
Rpl36a-ps2 |
ribosomal protein L36A, pseudogene 2 |
11496 |
0.18 |
chr13_51569404_51569586 | 20.32 |
Shc3 |
src homology 2 domain-containing transforming protein C3 |
8 |
0.98 |
chr14_5502289_5502728 | 20.19 |
Gm3488 |
predicted gene, 3488 |
834 |
0.47 |
chr9_35331151_35331788 | 20.10 |
Gm33838 |
predicted gene, 33838 |
23870 |
0.11 |
chr1_160351863_160352201 | 20.07 |
Rabgap1l |
RAB GTPase activating protein 1-like |
461 |
0.79 |
chr3_34559225_34559387 | 19.98 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
1022 |
0.48 |
chr13_84064676_84065083 | 19.91 |
Gm17750 |
predicted gene, 17750 |
107 |
0.97 |
chr4_109762760_109763127 | 19.91 |
Gm12808 |
predicted gene 12808 |
8126 |
0.24 |
chr10_23674681_23675112 | 19.79 |
4930520K02Rik |
RIKEN cDNA 4930520K02 gene |
52748 |
0.11 |
chr15_25753020_25753269 | 19.77 |
Myo10 |
myosin X |
165 |
0.96 |
chr14_118230432_118230634 | 19.75 |
Gm4675 |
predicted gene 4675 |
5699 |
0.14 |
chr10_13107920_13108404 | 19.75 |
Plagl1 |
pleiomorphic adenoma gene-like 1 |
5303 |
0.23 |
chr3_126994207_126994654 | 19.73 |
Ank2 |
ankyrin 2, brain |
4008 |
0.14 |
chr13_116497636_116498069 | 19.70 |
Gm47912 |
predicted gene, 47912 |
136158 |
0.05 |
chr7_75983169_75983876 | 19.69 |
Gm45139 |
predicted gene 45139 |
17302 |
0.24 |
chr14_5960610_5960983 | 19.66 |
Gm3248 |
predicted gene 3248 |
949 |
0.39 |
chr3_88232209_88232744 | 19.63 |
Gm3764 |
predicted gene 3764 |
3693 |
0.1 |
chr8_54954036_54954355 | 19.53 |
Gpm6a |
glycoprotein m6a |
648 |
0.67 |
chr12_10874948_10875116 | 19.53 |
Pgk1-rs7 |
phosphoglycerate kinase-1, related sequence-7 |
25208 |
0.23 |
chr17_7700126_7700299 | 19.52 |
Gm25872 |
predicted gene, 25872 |
4628 |
0.26 |
chr18_52808472_52808700 | 19.37 |
Gm50457 |
predicted gene, 50457 |
16724 |
0.21 |
chr9_110053315_110053992 | 19.35 |
Map4 |
microtubule-associated protein 4 |
1601 |
0.28 |
chr13_34096148_34096452 | 19.25 |
Gm47065 |
predicted gene, 47065 |
7273 |
0.1 |
chr4_5957013_5957332 | 19.24 |
Gm11796 |
predicted gene 11796 |
101685 |
0.07 |
chr9_36881381_36881946 | 19.11 |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
11160 |
0.19 |
chr18_78454680_78455309 | 19.08 |
4931439C15Rik |
RIKEN cDNA 4931439C15 gene |
21884 |
0.23 |
chr10_52742737_52743261 | 19.06 |
Gm47624 |
predicted gene, 47624 |
49161 |
0.11 |
chr1_165934961_165935308 | 18.99 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
123 |
0.95 |
chr3_105538840_105539458 | 18.96 |
Gm43847 |
predicted gene 43847 |
36242 |
0.16 |
chr10_106609257_106609592 | 18.93 |
4930532I03Rik |
RIKEN cDNA 4930532I03 gene |
6944 |
0.29 |
chr1_175492264_175493051 | 18.92 |
Rgs7 |
regulator of G protein signaling 7 |
157 |
0.97 |
chr5_47557232_47557404 | 18.90 |
Gm17824 |
predicted gene, 17824 |
77184 |
0.12 |
chr5_99274158_99274645 | 18.86 |
Gm35394 |
predicted gene, 35394 |
306 |
0.92 |
chr5_40295141_40295321 | 18.75 |
Gm2810 |
predicted pseudogene 2810 |
33207 |
0.24 |
chr12_83044975_83045325 | 18.71 |
Rgs6 |
regulator of G-protein signaling 6 |
1840 |
0.38 |
chr16_79870693_79870877 | 18.69 |
Rps19-ps12 |
ribosomal protein S19, pseudogene 12 |
44086 |
0.2 |
chr16_35613873_35614640 | 18.62 |
Gm5963 |
predicted pseudogene 5963 |
40700 |
0.13 |
chr9_90693038_90693253 | 18.60 |
Gm2497 |
predicted gene 2497 |
40379 |
0.14 |
chr12_28460953_28461147 | 18.59 |
Dcdc2c |
doublecortin domain containing 2C |
55664 |
0.11 |
chr16_77536418_77536599 | 18.57 |
Gm36963 |
predicted gene, 36963 |
3374 |
0.16 |
chr19_9143694_9144136 | 18.49 |
Asrgl1 |
asparaginase like 1 |
8279 |
0.15 |
chr3_11024565_11024725 | 18.43 |
Gm21631 |
predicted gene, 21631 |
15042 |
0.2 |
chr11_19523869_19524493 | 18.40 |
Gm12027 |
predicted gene 12027 |
103880 |
0.07 |
chr8_73355535_73355806 | 18.40 |
Large1 |
LARGE xylosyl- and glucuronyltransferase 1 |
2130 |
0.44 |
chr10_13117108_13117586 | 18.40 |
Plagl1 |
pleiomorphic adenoma gene-like 1 |
983 |
0.59 |
chr5_84848501_84849167 | 18.39 |
Gm21006 |
predicted gene, 21006 |
18011 |
0.3 |
chr8_4677704_4678740 | 18.28 |
Gm7461 |
predicted gene 7461 |
143 |
0.62 |
chr3_4546148_4546485 | 18.27 |
Gm22944 |
predicted gene, 22944 |
21019 |
0.21 |
chr3_19828579_19828797 | 18.26 |
Gm7442 |
predicted gene 7442 |
59815 |
0.1 |
chr5_131645868_131646247 | 18.24 |
Gm43483 |
predicted gene 43483 |
3250 |
0.16 |
chr3_65658032_65658183 | 18.14 |
Mir8120 |
microRNA 8120 |
1181 |
0.4 |
chr15_30693718_30694224 | 18.14 |
Ctnnd2 |
catenin (cadherin associated protein), delta 2 |
10812 |
0.25 |
chr1_63763173_63763740 | 18.12 |
4933402D24Rik |
RIKEN cDNA 4933402D24 gene |
5811 |
0.18 |
chr19_26770137_26770516 | 18.04 |
Smarca2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
165 |
0.96 |
chr6_36776057_36776246 | 17.97 |
Ptn |
pleiotrophin |
34028 |
0.2 |
chr13_34148695_34149213 | 17.95 |
Psmg4 |
proteasome (prosome, macropain) assembly chaperone 4 |
14010 |
0.11 |
chr3_116321462_116321795 | 17.90 |
Gm29151 |
predicted gene 29151 |
28475 |
0.15 |
chr13_39524261_39524439 | 17.84 |
Gm47351 |
predicted gene, 47351 |
8753 |
0.2 |
chr2_142334870_142335066 | 17.80 |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
158361 |
0.04 |
chr14_24617341_24617911 | 17.76 |
4930428N03Rik |
RIKEN cDNA 4930428N03 gene |
58 |
0.64 |
chr14_3810787_3811147 | 17.75 |
Gm3002 |
predicted gene 3002 |
893 |
0.48 |
chr1_3094927_3095127 | 17.73 |
Gm26206 |
predicted gene, 26206 |
6989 |
0.25 |
chr2_6594788_6595061 | 17.71 |
Celf2 |
CUGBP, Elav-like family member 2 |
2124 |
0.42 |
chr13_28792466_28792753 | 17.64 |
Gm17528 |
predicted gene, 17528 |
34514 |
0.16 |
chr3_75395621_75395830 | 17.60 |
Gm17836 |
predicted gene, 17836 |
4406 |
0.28 |
chr2_118444281_118444538 | 17.59 |
Eif2ak4 |
eukaryotic translation initiation factor 2 alpha kinase 4 |
5567 |
0.18 |
chr4_152834006_152834205 | 17.55 |
Gm833 |
predicted gene 833 |
136565 |
0.05 |
chr18_20624320_20624587 | 17.54 |
Gm16090 |
predicted gene 16090 |
40807 |
0.12 |
chr10_5032307_5032619 | 17.52 |
Gm25694 |
predicted gene, 25694 |
3993 |
0.24 |
chr13_71139064_71139215 | 17.48 |
Mir466f-4 |
microRNA 466f-4 |
32050 |
0.22 |
chr2_29465808_29466040 | 17.47 |
Gm24976 |
predicted gene, 24976 |
6730 |
0.16 |
chr1_109972184_109972393 | 17.45 |
Cdh7 |
cadherin 7, type 2 |
10143 |
0.31 |
chr18_78455374_78455574 | 17.40 |
4931439C15Rik |
RIKEN cDNA 4931439C15 gene |
21404 |
0.24 |
chr6_110205910_110206254 | 17.38 |
Gm19039 |
predicted gene, 19039 |
171972 |
0.04 |
chr3_118626529_118626766 | 17.36 |
Dpyd |
dihydropyrimidine dehydrogenase |
64461 |
0.11 |
chr3_50421873_50422272 | 17.31 |
Gm37498 |
predicted gene, 37498 |
17789 |
0.21 |
chr11_6606254_6606619 | 17.30 |
Nacad |
NAC alpha domain containing |
383 |
0.7 |
chr9_91365711_91366045 | 17.29 |
Zic1 |
zinc finger protein of the cerebellum 1 |
68 |
0.95 |
chr10_37803452_37803603 | 17.25 |
Gm24710 |
predicted gene, 24710 |
128153 |
0.06 |
chr5_70843452_70843631 | 17.23 |
Gabrg1 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 1 |
924 |
0.74 |
chr10_108701744_108702064 | 17.11 |
Gm5136 |
predicted gene 5136 |
1744 |
0.46 |
chr14_12393119_12393544 | 17.10 |
Gm48267 |
predicted gene, 48267 |
8899 |
0.14 |
chr10_44887350_44887727 | 17.08 |
Gm47398 |
predicted gene, 47398 |
20752 |
0.15 |
chr2_53385345_53385496 | 17.07 |
Gm13501 |
predicted gene 13501 |
13067 |
0.28 |
chr14_6888825_6889165 | 17.07 |
Gm3667 |
predicted gene 3667 |
967 |
0.55 |
chr12_12877548_12878341 | 17.06 |
Gm48187 |
predicted gene, 48187 |
12374 |
0.14 |
chr8_23562129_23562317 | 17.00 |
Zmat4 |
zinc finger, matrin type 4 |
73796 |
0.11 |
chr10_49220217_49220390 | 16.97 |
Gm26543 |
predicted gene, 26543 |
5350 |
0.19 |
chr7_61939801_61940302 | 16.94 |
Mir344-2 |
microRNA 344-2 |
55 |
0.95 |
chr6_58933581_58933791 | 16.93 |
Herc3 |
hect domain and RLD 3 |
26424 |
0.12 |
chr4_71316698_71316877 | 16.92 |
Gm11229 |
predicted gene 11229 |
30845 |
0.22 |
chrX_52369390_52369575 | 16.91 |
Mir6384 |
microRNA 6384 |
8699 |
0.24 |
chr2_57378479_57378900 | 16.90 |
Gm13531 |
predicted gene 13531 |
47020 |
0.16 |
chr5_39260966_39261118 | 16.89 |
Gm40293 |
predicted gene, 40293 |
46042 |
0.14 |
chr2_94246412_94247550 | 16.88 |
Mir670hg |
MIR670 host gene (non-protein coding) |
3643 |
0.17 |
chr10_46827443_46827788 | 16.82 |
Gm25650 |
predicted gene, 25650 |
10892 |
0.24 |
chr9_16484808_16485485 | 16.77 |
Fat3 |
FAT atypical cadherin 3 |
16139 |
0.27 |
chr6_8956269_8957017 | 16.73 |
Nxph1 |
neurexophilin 1 |
6967 |
0.32 |
chr15_44707069_44707237 | 16.73 |
Sybu |
syntabulin (syntaxin-interacting) |
40635 |
0.15 |
chr18_67497794_67498327 | 16.71 |
Spire1 |
spire type actin nucleation factor 1 |
331 |
0.86 |
chr18_73369664_73369876 | 16.68 |
n-R5-8s1 |
nuclear encoded rRNA 5.8S 1 |
163780 |
0.04 |
chr8_90870425_90870812 | 16.67 |
Gm45640 |
predicted gene 45640 |
5963 |
0.14 |
chr18_81251894_81252538 | 16.65 |
Gm30192 |
predicted gene, 30192 |
12475 |
0.22 |
chr8_17587417_17587764 | 16.57 |
Csmd1 |
CUB and Sushi multiple domains 1 |
52004 |
0.19 |
chr16_72959177_72959642 | 16.51 |
Robo1 |
roundabout guidance receptor 1 |
16940 |
0.29 |
chr4_15550428_15550614 | 16.49 |
Gm11859 |
predicted gene 11859 |
18410 |
0.22 |
chr14_48012437_48012848 | 16.49 |
Gm49305 |
predicted gene, 49305 |
18701 |
0.13 |
chr8_98309461_98309682 | 16.48 |
Gm7192 |
predicted gene 7192 |
84908 |
0.1 |
chr7_29071400_29071669 | 16.42 |
Gm26604 |
predicted gene, 26604 |
69 |
0.87 |
chr2_137807995_137808203 | 16.39 |
Gm14062 |
predicted gene 14062 |
68732 |
0.14 |
chr5_99504299_99504831 | 16.38 |
Gm35172 |
predicted gene, 35172 |
3824 |
0.24 |
chr18_80984653_80984858 | 16.36 |
Sall3 |
spalt like transcription factor 3 |
1781 |
0.25 |
chr10_57784204_57784403 | 16.25 |
Fabp7 |
fatty acid binding protein 7, brain |
578 |
0.69 |
chr6_39493029_39493678 | 16.20 |
Dennd2a |
DENN/MADD domain containing 2A |
4187 |
0.19 |
chr1_179327030_179327181 | 16.19 |
Smyd3 |
SET and MYND domain containing 3 |
46998 |
0.18 |
chr2_136759053_136759378 | 16.17 |
Gm14053 |
predicted gene 14053 |
14600 |
0.21 |
chr1_144177501_144177652 | 16.12 |
Rgs13 |
regulator of G-protein signaling 13 |
204 |
0.96 |
chr8_7267537_7267688 | 16.11 |
Gm44908 |
predicted gene 44908 |
36378 |
0.21 |
chr1_175692535_175693373 | 16.09 |
Chml |
choroideremia-like |
53 |
0.67 |
chr3_69178319_69178527 | 16.06 |
Arl14 |
ADP-ribosylation factor-like 14 |
43996 |
0.1 |
chr10_84822817_84823117 | 16.05 |
Rfx4 |
regulatory factor X, 4 (influences HLA class II expression) |
11779 |
0.2 |
chr18_25378079_25378424 | 16.04 |
Gm16558 |
predicted gene 16558 |
13550 |
0.27 |
chr12_44462981_44463367 | 16.03 |
Nrcam |
neuronal cell adhesion molecule |
6514 |
0.25 |
chr13_84448589_84449243 | 16.00 |
Gm26927 |
predicted gene, 26927 |
108803 |
0.07 |
chr2_147188347_147188530 | 15.96 |
6430503K07Rik |
RIKEN cDNA 6430503K07 gene |
1014 |
0.42 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
35.4 | 106.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
15.2 | 45.5 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
10.2 | 61.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
10.1 | 40.5 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
10.1 | 91.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
9.4 | 28.2 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
9.3 | 9.3 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
8.2 | 24.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
8.1 | 56.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
7.8 | 31.0 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
7.7 | 23.1 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
7.6 | 30.3 | GO:0007412 | axon target recognition(GO:0007412) |
7.3 | 58.2 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
7.2 | 43.3 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
7.1 | 28.5 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
6.8 | 20.5 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
6.6 | 19.9 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
6.6 | 26.3 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
6.5 | 6.5 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
6.2 | 31.2 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
6.2 | 24.8 | GO:0060594 | mammary gland specification(GO:0060594) |
6.1 | 18.2 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
6.0 | 18.1 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
6.0 | 12.1 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
5.8 | 11.6 | GO:0071873 | response to norepinephrine(GO:0071873) |
5.7 | 5.7 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
5.7 | 34.0 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
5.6 | 67.8 | GO:0097120 | receptor localization to synapse(GO:0097120) |
5.5 | 27.7 | GO:0021764 | amygdala development(GO:0021764) |
5.5 | 71.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
5.4 | 16.2 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
5.3 | 16.0 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
5.2 | 15.7 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
5.2 | 20.7 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
5.2 | 10.3 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
5.1 | 15.2 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
4.9 | 9.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
4.9 | 19.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
4.7 | 23.7 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
4.7 | 103.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
4.7 | 14.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
4.6 | 9.2 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
4.6 | 4.6 | GO:0061642 | chemoattraction of axon(GO:0061642) |
4.6 | 18.3 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
4.5 | 22.7 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
4.5 | 22.5 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
4.5 | 9.0 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
4.5 | 13.4 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
4.5 | 13.4 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
4.4 | 17.6 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
4.4 | 8.7 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
4.3 | 13.0 | GO:0030070 | insulin processing(GO:0030070) |
4.2 | 21.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
4.2 | 33.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
4.1 | 24.9 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
4.1 | 12.3 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
4.1 | 12.3 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
4.0 | 16.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
4.0 | 12.0 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
3.9 | 98.6 | GO:0035640 | exploration behavior(GO:0035640) |
3.9 | 11.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
3.9 | 27.1 | GO:0050957 | equilibrioception(GO:0050957) |
3.8 | 11.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
3.8 | 15.0 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
3.8 | 7.5 | GO:0042940 | D-amino acid transport(GO:0042940) |
3.7 | 14.9 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
3.6 | 7.3 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
3.6 | 57.8 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
3.6 | 10.8 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
3.6 | 10.7 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
3.6 | 49.9 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
3.6 | 14.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
3.5 | 10.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
3.5 | 3.5 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
3.4 | 6.9 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
3.4 | 10.3 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
3.4 | 6.9 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
3.3 | 16.6 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
3.3 | 13.3 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
3.3 | 13.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
3.3 | 13.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
3.2 | 16.2 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
3.2 | 19.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
3.2 | 9.6 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
3.2 | 9.5 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
3.1 | 18.9 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
3.1 | 53.3 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
3.1 | 18.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
3.1 | 18.4 | GO:0022605 | oogenesis stage(GO:0022605) |
3.0 | 9.1 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
3.0 | 12.1 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
3.0 | 15.1 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
3.0 | 24.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
3.0 | 9.0 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
3.0 | 9.0 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
3.0 | 3.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
3.0 | 8.9 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
3.0 | 26.6 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
2.9 | 8.8 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
2.9 | 8.8 | GO:0051182 | coenzyme transport(GO:0051182) |
2.9 | 2.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
2.9 | 5.8 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
2.9 | 2.9 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
2.9 | 8.7 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
2.9 | 20.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
2.9 | 8.7 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
2.9 | 8.6 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
2.9 | 8.6 | GO:0060174 | limb bud formation(GO:0060174) |
2.9 | 25.8 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
2.8 | 11.4 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
2.8 | 11.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
2.8 | 8.5 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
2.8 | 8.5 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
2.8 | 14.0 | GO:0071625 | vocalization behavior(GO:0071625) |
2.8 | 11.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
2.8 | 8.3 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
2.8 | 8.3 | GO:0061743 | motor learning(GO:0061743) |
2.8 | 11.0 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
2.7 | 8.2 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
2.7 | 11.0 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
2.7 | 2.7 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
2.7 | 18.8 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
2.7 | 10.7 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
2.7 | 13.4 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
2.7 | 2.7 | GO:0021586 | pons maturation(GO:0021586) |
2.7 | 5.3 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
2.6 | 10.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
2.6 | 7.9 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
2.6 | 2.6 | GO:0042420 | dopamine catabolic process(GO:0042420) |
2.6 | 2.6 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
2.6 | 5.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
2.5 | 197.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
2.5 | 7.5 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
2.5 | 121.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
2.5 | 4.9 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
2.5 | 2.5 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
2.4 | 7.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
2.4 | 7.3 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
2.4 | 4.9 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
2.4 | 21.9 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
2.4 | 7.2 | GO:0090135 | actin filament branching(GO:0090135) |
2.4 | 7.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
2.4 | 12.0 | GO:0010587 | miRNA catabolic process(GO:0010587) |
2.4 | 4.7 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
2.4 | 4.7 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
2.3 | 21.1 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
2.3 | 9.4 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
2.3 | 7.0 | GO:0021871 | forebrain regionalization(GO:0021871) |
2.3 | 2.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
2.3 | 6.9 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
2.3 | 2.3 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
2.3 | 6.9 | GO:0060179 | male mating behavior(GO:0060179) |
2.3 | 70.7 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
2.3 | 2.3 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
2.3 | 15.8 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
2.3 | 4.5 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
2.2 | 6.7 | GO:1990034 | calcium ion export from cell(GO:1990034) |
2.2 | 6.7 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
2.2 | 6.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
2.2 | 8.8 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
2.2 | 6.5 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
2.2 | 4.3 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
2.2 | 4.3 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
2.1 | 6.4 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
2.1 | 8.6 | GO:0030035 | microspike assembly(GO:0030035) |
2.1 | 10.7 | GO:0008038 | neuron recognition(GO:0008038) |
2.1 | 8.5 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
2.1 | 2.1 | GO:1904023 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
2.1 | 16.8 | GO:0001964 | startle response(GO:0001964) |
2.1 | 2.1 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
2.1 | 8.3 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
2.1 | 4.2 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
2.1 | 4.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
2.1 | 4.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
2.1 | 6.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
2.0 | 4.1 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
2.0 | 6.0 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
2.0 | 6.0 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
2.0 | 4.0 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
2.0 | 7.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
2.0 | 5.9 | GO:0046881 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
2.0 | 7.8 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.9 | 5.8 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
1.9 | 7.8 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
1.9 | 11.7 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
1.9 | 7.7 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
1.9 | 5.8 | GO:0060676 | ureteric bud formation(GO:0060676) |
1.9 | 9.6 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
1.9 | 5.8 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.9 | 7.6 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
1.9 | 3.8 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.9 | 13.3 | GO:0086014 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
1.9 | 7.5 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
1.9 | 9.4 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.9 | 5.6 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
1.9 | 5.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.9 | 1.9 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
1.8 | 3.7 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
1.8 | 7.4 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
1.8 | 20.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.8 | 1.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.8 | 1.8 | GO:0048880 | sensory system development(GO:0048880) |
1.8 | 1.8 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.8 | 3.6 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
1.8 | 1.8 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
1.8 | 5.3 | GO:0030242 | pexophagy(GO:0030242) |
1.8 | 3.6 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.8 | 16.0 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
1.8 | 7.0 | GO:0030091 | protein repair(GO:0030091) |
1.7 | 7.0 | GO:0051697 | protein delipidation(GO:0051697) |
1.7 | 7.0 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
1.7 | 3.5 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
1.7 | 5.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.7 | 8.7 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
1.7 | 3.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.7 | 1.7 | GO:0034650 | cortisol metabolic process(GO:0034650) |
1.7 | 1.7 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
1.7 | 3.4 | GO:0046959 | habituation(GO:0046959) |
1.7 | 15.4 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
1.7 | 53.0 | GO:0021954 | central nervous system neuron development(GO:0021954) |
1.7 | 22.0 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
1.7 | 10.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
1.7 | 3.3 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
1.7 | 3.3 | GO:0021747 | cochlear nucleus development(GO:0021747) |
1.7 | 14.9 | GO:0060074 | synapse maturation(GO:0060074) |
1.6 | 4.9 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
1.6 | 4.9 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.6 | 3.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
1.6 | 3.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
1.6 | 4.9 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
1.6 | 6.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.6 | 16.3 | GO:0046847 | filopodium assembly(GO:0046847) |
1.6 | 8.1 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
1.6 | 19.4 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
1.6 | 3.2 | GO:0021794 | thalamus development(GO:0021794) |
1.6 | 3.2 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
1.6 | 4.8 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
1.6 | 4.8 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
1.6 | 1.6 | GO:0072235 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
1.6 | 7.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.6 | 11.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
1.6 | 1.6 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
1.6 | 1.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.6 | 1.6 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
1.6 | 1.6 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
1.6 | 15.5 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
1.5 | 3.1 | GO:0060166 | olfactory pit development(GO:0060166) |
1.5 | 6.1 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
1.5 | 10.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
1.5 | 4.6 | GO:0010046 | response to mycotoxin(GO:0010046) |
1.5 | 6.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.5 | 12.1 | GO:0034331 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
1.5 | 6.0 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
1.5 | 1.5 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
1.5 | 17.9 | GO:0021879 | forebrain neuron differentiation(GO:0021879) |
1.5 | 7.4 | GO:0006528 | asparagine metabolic process(GO:0006528) |
1.5 | 2.9 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
1.5 | 10.2 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
1.5 | 7.3 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
1.4 | 1.4 | GO:0001997 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
1.4 | 104.0 | GO:0007612 | learning(GO:0007612) |
1.4 | 34.7 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
1.4 | 1.4 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
1.4 | 4.3 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
1.4 | 5.7 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
1.4 | 10.0 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.4 | 1.4 | GO:0035973 | aggrephagy(GO:0035973) |
1.4 | 4.2 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
1.4 | 2.8 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
1.4 | 7.0 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
1.4 | 4.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
1.4 | 13.6 | GO:0017121 | phospholipid scrambling(GO:0017121) |
1.4 | 2.7 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
1.4 | 2.7 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
1.4 | 6.8 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
1.3 | 1.3 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
1.3 | 9.4 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
1.3 | 4.0 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
1.3 | 4.0 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.3 | 2.6 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.3 | 23.7 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
1.3 | 1.3 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.3 | 2.6 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
1.3 | 6.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
1.3 | 1.3 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
1.3 | 6.5 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
1.3 | 3.9 | GO:0021854 | hypothalamus development(GO:0021854) |
1.3 | 3.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
1.3 | 6.4 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
1.3 | 3.8 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
1.3 | 1.3 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
1.3 | 1.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
1.2 | 3.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
1.2 | 8.7 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
1.2 | 4.9 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
1.2 | 1.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
1.2 | 6.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
1.2 | 4.8 | GO:0010165 | response to X-ray(GO:0010165) |
1.2 | 2.4 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
1.2 | 4.8 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
1.2 | 6.0 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
1.2 | 10.7 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
1.2 | 1.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.2 | 40.1 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
1.2 | 3.5 | GO:0007638 | mechanosensory behavior(GO:0007638) |
1.2 | 5.8 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
1.2 | 7.0 | GO:0048840 | otolith development(GO:0048840) |
1.2 | 4.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.2 | 3.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
1.2 | 2.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
1.1 | 3.4 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.1 | 1.1 | GO:0031133 | regulation of axon diameter(GO:0031133) |
1.1 | 8.0 | GO:0042436 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
1.1 | 2.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.1 | 5.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.1 | 15.8 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
1.1 | 4.5 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.1 | 2.2 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
1.1 | 2.2 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
1.1 | 2.2 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
1.1 | 5.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
1.1 | 5.3 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
1.1 | 10.6 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
1.0 | 4.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
1.0 | 5.2 | GO:0021544 | subpallium development(GO:0021544) |
1.0 | 11.3 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
1.0 | 3.1 | GO:0042637 | catagen(GO:0042637) |
1.0 | 3.1 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
1.0 | 2.0 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
1.0 | 2.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
1.0 | 3.0 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
1.0 | 7.0 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
1.0 | 7.9 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
1.0 | 2.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
1.0 | 3.9 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
1.0 | 2.9 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) nucleoside salvage(GO:0043174) |
1.0 | 2.9 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
1.0 | 1.0 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
1.0 | 1.9 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
1.0 | 3.9 | GO:0042402 | cellular biogenic amine catabolic process(GO:0042402) |
1.0 | 4.8 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.0 | 3.8 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
1.0 | 21.0 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.9 | 0.9 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.9 | 1.9 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.9 | 2.8 | GO:0097503 | sialylation(GO:0097503) |
0.9 | 2.8 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.9 | 2.8 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.9 | 7.4 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.9 | 15.8 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.9 | 1.9 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.9 | 1.8 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.9 | 0.9 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.9 | 3.7 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.9 | 1.8 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.9 | 3.6 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.9 | 1.8 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.9 | 2.7 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.9 | 1.8 | GO:0015888 | thiamine transport(GO:0015888) |
0.9 | 1.8 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.9 | 5.4 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.9 | 0.9 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.9 | 1.8 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.9 | 0.9 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
0.9 | 5.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.9 | 0.9 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.9 | 2.6 | GO:0015800 | acidic amino acid transport(GO:0015800) |
0.9 | 2.6 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.9 | 4.4 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.9 | 0.9 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.9 | 1.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.9 | 4.3 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.9 | 5.2 | GO:0009074 | aromatic amino acid family catabolic process(GO:0009074) |
0.9 | 3.4 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.9 | 1.7 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.9 | 0.9 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.8 | 3.4 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.8 | 0.8 | GO:1903416 | response to glycoside(GO:1903416) |
0.8 | 6.7 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.8 | 1.7 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.8 | 3.3 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.8 | 1.7 | GO:2000118 | sodium-dependent phosphate transport(GO:0044341) regulation of sodium-dependent phosphate transport(GO:2000118) |
0.8 | 0.8 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.8 | 8.2 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.8 | 0.8 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.8 | 2.4 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.8 | 4.8 | GO:0015884 | folic acid transport(GO:0015884) |
0.8 | 8.0 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.8 | 6.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.8 | 2.4 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.8 | 3.9 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.8 | 1.6 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.8 | 1.6 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.8 | 3.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.8 | 3.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.8 | 1.6 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.8 | 1.6 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.8 | 0.8 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.8 | 2.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.8 | 0.8 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.8 | 1.5 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.8 | 2.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.7 | 0.7 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.7 | 1.5 | GO:0015705 | iodide transport(GO:0015705) |
0.7 | 2.2 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.7 | 2.2 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.7 | 0.7 | GO:0072679 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.7 | 0.7 | GO:0086068 | Purkinje myocyte action potential(GO:0086017) Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.7 | 2.2 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.7 | 5.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.7 | 4.4 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.7 | 2.2 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.7 | 2.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.7 | 1.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.7 | 0.7 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.7 | 3.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.7 | 6.3 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.7 | 3.5 | GO:0051013 | microtubule severing(GO:0051013) |
0.7 | 4.2 | GO:0060736 | prostate gland growth(GO:0060736) |
0.7 | 1.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.7 | 1.4 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.7 | 4.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.7 | 0.7 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.7 | 0.7 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.7 | 2.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.7 | 0.7 | GO:0099612 | protein localization to axon(GO:0099612) |
0.7 | 2.7 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.7 | 3.4 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.7 | 4.1 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.7 | 2.0 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.7 | 1.3 | GO:0060005 | vestibular reflex(GO:0060005) |
0.7 | 1.3 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.7 | 2.6 | GO:0035627 | ceramide transport(GO:0035627) |
0.7 | 0.7 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.7 | 9.8 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.7 | 23.5 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.6 | 9.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.6 | 1.3 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.6 | 0.6 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.6 | 1.9 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.6 | 2.5 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.6 | 0.6 | GO:0098739 | import across plasma membrane(GO:0098739) |
0.6 | 1.9 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.6 | 5.7 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.6 | 1.9 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.6 | 1.3 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.6 | 1.3 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.6 | 0.6 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) positive regulation of tooth mineralization(GO:0070172) |
0.6 | 1.2 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.6 | 3.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.6 | 5.0 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.6 | 1.8 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.6 | 6.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.6 | 1.8 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.6 | 0.6 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.6 | 1.2 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.6 | 1.8 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.6 | 3.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.6 | 1.8 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.6 | 1.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.6 | 1.8 | GO:0021554 | optic nerve development(GO:0021554) |
0.6 | 3.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.6 | 3.6 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.6 | 0.6 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.6 | 1.2 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.6 | 2.4 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.6 | 4.2 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.6 | 2.4 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.6 | 2.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.6 | 0.6 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.6 | 5.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.6 | 2.8 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.6 | 1.7 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.5 | 2.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.5 | 2.2 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.5 | 4.9 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.5 | 0.5 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.5 | 2.2 | GO:0099622 | cardiac muscle cell membrane repolarization(GO:0099622) |
0.5 | 2.1 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.5 | 2.1 | GO:0003157 | endocardium development(GO:0003157) |
0.5 | 5.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.5 | 1.6 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.5 | 2.1 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.5 | 7.3 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.5 | 1.6 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.5 | 0.5 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.5 | 1.0 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.5 | 3.1 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.5 | 0.5 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.5 | 1.0 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.5 | 2.0 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.5 | 4.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.5 | 1.0 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.5 | 5.0 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.5 | 1.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.5 | 0.5 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.5 | 1.0 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.5 | 1.5 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.5 | 1.0 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.5 | 2.0 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.5 | 2.0 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.5 | 1.0 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.5 | 1.0 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.5 | 1.5 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.5 | 1.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.5 | 1.5 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.5 | 0.5 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.5 | 1.0 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.5 | 1.4 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.5 | 0.9 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.5 | 0.5 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.5 | 3.2 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) |
0.5 | 1.4 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.5 | 1.4 | GO:0048254 | snoRNA localization(GO:0048254) |
0.5 | 3.6 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.5 | 4.5 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.5 | 0.5 | GO:0009629 | response to gravity(GO:0009629) |
0.4 | 1.3 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.4 | 0.4 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.4 | 12.2 | GO:0006813 | potassium ion transport(GO:0006813) |
0.4 | 2.2 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.4 | 3.0 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.4 | 2.2 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.4 | 0.4 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.4 | 0.9 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.4 | 2.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.4 | 1.3 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.4 | 3.8 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.4 | 0.4 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.4 | 1.7 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.4 | 1.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.4 | 0.4 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.4 | 0.8 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.4 | 0.4 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.4 | 2.5 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.4 | 1.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.4 | 0.4 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.4 | 0.8 | GO:1902896 | terminal web assembly(GO:1902896) |
0.4 | 2.4 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.4 | 0.8 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.4 | 1.6 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.4 | 0.4 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.4 | 2.7 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.4 | 5.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.4 | 6.1 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.4 | 0.8 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.4 | 1.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.4 | 1.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.4 | 0.4 | GO:0014848 | urinary tract smooth muscle contraction(GO:0014848) |
0.4 | 1.8 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.4 | 9.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.4 | 6.6 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.4 | 0.4 | GO:0090427 | activation of meiosis(GO:0090427) |
0.4 | 1.1 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.4 | 0.7 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.4 | 0.4 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.4 | 1.1 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.4 | 3.9 | GO:0036065 | fucosylation(GO:0036065) |
0.4 | 2.1 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.4 | 1.1 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.4 | 2.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.3 | 0.3 | GO:0060435 | bronchiole development(GO:0060435) |
0.3 | 4.9 | GO:0044346 | fibroblast apoptotic process(GO:0044346) |
0.3 | 1.7 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
0.3 | 0.7 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.3 | 1.0 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.3 | 0.7 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.3 | 1.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.3 | 1.3 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.3 | 1.0 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.3 | 0.3 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.3 | 1.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 1.0 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.3 | 2.8 | GO:0008347 | glial cell migration(GO:0008347) |
0.3 | 3.2 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.3 | 2.8 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.3 | 29.3 | GO:0071804 | cellular potassium ion transport(GO:0071804) |
0.3 | 2.1 | GO:0060914 | heart formation(GO:0060914) |
0.3 | 0.3 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.3 | 3.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.3 | 3.0 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.3 | 0.9 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 0.9 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.3 | 0.6 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.3 | 1.5 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.3 | 0.9 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.3 | 3.3 | GO:0021766 | hippocampus development(GO:0021766) |
0.3 | 0.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.3 | 0.9 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.3 | 2.3 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.3 | 0.3 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
0.3 | 1.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.3 | 3.7 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.3 | 0.6 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.3 | 4.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.3 | 0.8 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.3 | 2.0 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.3 | 0.6 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.3 | 1.9 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 0.8 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 1.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.3 | 4.9 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.3 | 0.3 | GO:0060618 | nipple development(GO:0060618) |
0.3 | 2.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 0.8 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.3 | 1.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.3 | 0.3 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.3 | 6.1 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.3 | 0.3 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.3 | 2.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 0.8 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.3 | 1.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.3 | 0.5 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.3 | 2.5 | GO:0010842 | retina layer formation(GO:0010842) |
0.3 | 1.5 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 1.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.2 | 0.5 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 0.7 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.2 | 0.7 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.2 | 0.5 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.2 | 0.5 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.2 | 3.3 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 1.9 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.2 | 11.1 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.2 | 3.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.2 | 0.5 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.2 | 0.2 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.2 | 1.4 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.2 | 10.2 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.2 | 0.9 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.2 | 0.2 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.2 | 0.2 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.2 | 0.7 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 3.0 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.2 | 0.2 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.2 | 0.6 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.2 | 0.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.6 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) skeletal muscle satellite cell activation(GO:0014719) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.2 | 0.6 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 0.6 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.2 | 0.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 1.6 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.2 | 0.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.2 | 0.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 1.2 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.2 | 0.6 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.2 | 0.9 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.2 | 0.6 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 0.4 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.2 | 1.4 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.2 | 1.8 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.2 | 1.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 0.5 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.2 | 4.4 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.2 | 1.3 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 0.5 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.2 | 1.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 1.1 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 1.0 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 1.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.2 | 6.7 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.2 | 0.6 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.1 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.1 | 0.1 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.1 | 1.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 1.1 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 0.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.6 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.7 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 1.1 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 2.8 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.1 | GO:0072126 | positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
0.1 | 0.7 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.3 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.1 | 0.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.1 | 1.4 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 1.0 | GO:0043574 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 0.6 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.8 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.4 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.8 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.1 | 0.3 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.2 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.9 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 0.3 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.4 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.3 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.1 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.1 | 0.4 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.3 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.1 | 0.5 | GO:0006582 | melanin metabolic process(GO:0006582) |
0.1 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 1.5 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.5 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.4 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.1 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.1 | 0.3 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 2.6 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.1 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.1 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.0 | 0.2 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.5 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.7 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.0 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.1 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.3 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.0 | 0.0 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.2 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.8 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.3 | GO:1904874 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.0 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.0 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.0 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.0 | 0.0 | GO:1901671 | regulation of superoxide dismutase activity(GO:1901668) positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
0.0 | 0.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.0 | GO:0061307 | cardiac neural crest cell differentiation involved in heart development(GO:0061307) cardiac neural crest cell development involved in heart development(GO:0061308) |
0.0 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.1 | GO:0007135 | meiosis II(GO:0007135) |
0.0 | 0.0 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 0.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.0 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.0 | 0.0 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.4 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.6 | 25.8 | GO:0097451 | glial limiting end-foot(GO:0097451) |
6.6 | 33.2 | GO:0097433 | dense body(GO:0097433) |
6.2 | 18.6 | GO:1990812 | growth cone filopodium(GO:1990812) |
6.0 | 60.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
5.7 | 28.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
5.2 | 41.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
4.7 | 14.2 | GO:0005914 | spot adherens junction(GO:0005914) |
4.7 | 32.8 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
4.7 | 55.9 | GO:0043194 | axon initial segment(GO:0043194) |
4.6 | 13.8 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
4.3 | 17.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
4.2 | 76.0 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
4.2 | 204.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
4.1 | 69.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
4.1 | 44.8 | GO:0032433 | filopodium tip(GO:0032433) |
3.9 | 7.8 | GO:0097441 | basilar dendrite(GO:0097441) |
3.7 | 11.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
3.6 | 36.3 | GO:0030673 | axolemma(GO:0030673) |
3.6 | 25.3 | GO:0032584 | growth cone membrane(GO:0032584) |
3.6 | 14.3 | GO:1990696 | USH2 complex(GO:1990696) |
3.6 | 14.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
3.6 | 14.2 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
3.6 | 14.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
3.5 | 3.5 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
3.5 | 10.4 | GO:0072534 | perineuronal net(GO:0072534) |
3.4 | 20.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
3.2 | 9.7 | GO:0070552 | BRISC complex(GO:0070552) |
3.1 | 64.2 | GO:0030057 | desmosome(GO:0030057) |
3.0 | 38.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
2.9 | 11.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
2.9 | 17.6 | GO:0016012 | sarcoglycan complex(GO:0016012) |
2.8 | 118.3 | GO:0043198 | dendritic shaft(GO:0043198) |
2.7 | 5.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
2.6 | 20.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
2.6 | 10.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
2.5 | 12.3 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
2.4 | 40.2 | GO:0044295 | axonal growth cone(GO:0044295) |
2.3 | 50.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
2.3 | 31.8 | GO:0031045 | dense core granule(GO:0031045) |
2.2 | 24.2 | GO:0044292 | dendrite terminus(GO:0044292) |
2.2 | 17.3 | GO:0071437 | invadopodium(GO:0071437) |
2.1 | 50.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
2.1 | 4.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
2.0 | 20.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
2.0 | 5.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
1.9 | 9.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.9 | 5.7 | GO:0043511 | inhibin complex(GO:0043511) |
1.9 | 5.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.8 | 20.1 | GO:0042555 | MCM complex(GO:0042555) |
1.8 | 19.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
1.7 | 10.3 | GO:0043083 | synaptic cleft(GO:0043083) |
1.7 | 3.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.7 | 233.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
1.6 | 3.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
1.6 | 75.6 | GO:0030175 | filopodium(GO:0030175) |
1.6 | 4.7 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
1.5 | 9.2 | GO:0030008 | TRAPP complex(GO:0030008) |
1.5 | 6.1 | GO:0097449 | astrocyte projection(GO:0097449) |
1.5 | 12.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.5 | 5.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.5 | 4.4 | GO:0000322 | storage vacuole(GO:0000322) |
1.5 | 14.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.5 | 10.2 | GO:0005688 | U6 snRNP(GO:0005688) |
1.4 | 26.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
1.4 | 6.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
1.3 | 6.7 | GO:0071547 | piP-body(GO:0071547) |
1.3 | 2.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.3 | 4.0 | GO:0033268 | node of Ranvier(GO:0033268) |
1.3 | 2.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.3 | 1.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.3 | 3.8 | GO:0048179 | activin receptor complex(GO:0048179) |
1.1 | 13.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
1.1 | 10.1 | GO:0036156 | inner dynein arm(GO:0036156) |
1.1 | 7.8 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
1.1 | 4.3 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
1.1 | 1.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
1.0 | 52.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
1.0 | 1.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.0 | 4.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
1.0 | 3.1 | GO:0036396 | MIS complex(GO:0036396) |
1.0 | 2.0 | GO:0044327 | dendritic spine head(GO:0044327) |
1.0 | 1.0 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
1.0 | 2.9 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.9 | 3.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.9 | 2.8 | GO:0042583 | chromaffin granule(GO:0042583) |
0.9 | 3.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.9 | 3.6 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.9 | 2.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.9 | 0.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.9 | 6.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.9 | 2.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.9 | 2.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.8 | 7.6 | GO:0097440 | apical dendrite(GO:0097440) |
0.8 | 5.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.8 | 6.6 | GO:0060091 | kinocilium(GO:0060091) |
0.8 | 8.9 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.8 | 2.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.8 | 7.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.8 | 56.6 | GO:0030426 | growth cone(GO:0030426) |
0.8 | 7.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.8 | 9.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.8 | 20.8 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.7 | 2.2 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.7 | 1.5 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.7 | 2.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.7 | 99.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.7 | 1.4 | GO:0042585 | germinal vesicle(GO:0042585) |
0.7 | 58.3 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.7 | 7.7 | GO:0033655 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.7 | 3.5 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.7 | 2.8 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.7 | 1.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.6 | 3.8 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.6 | 1.9 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.6 | 2.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.6 | 5.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.6 | 3.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.6 | 36.2 | GO:0043204 | perikaryon(GO:0043204) |
0.6 | 1.8 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.6 | 2.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.6 | 0.6 | GO:0044393 | microspike(GO:0044393) |
0.6 | 3.4 | GO:0002177 | manchette(GO:0002177) |
0.6 | 33.4 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.5 | 1.6 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.5 | 7.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.5 | 6.3 | GO:0034704 | calcium channel complex(GO:0034704) |
0.5 | 4.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.5 | 3.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.5 | 1.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.5 | 1.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.5 | 1.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.5 | 2.4 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.5 | 5.7 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.5 | 6.5 | GO:0071565 | nBAF complex(GO:0071565) |
0.5 | 1.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.5 | 3.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.4 | 3.1 | GO:0070187 | telosome(GO:0070187) |
0.4 | 6.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.4 | 3.8 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.4 | 2.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.4 | 0.4 | GO:0035838 | growing cell tip(GO:0035838) |
0.4 | 2.4 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.4 | 4.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.4 | 3.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.4 | 3.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.4 | 1.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.4 | 2.6 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.4 | 7.0 | GO:0005686 | U2 snRNP(GO:0005686) |
0.4 | 21.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.4 | 2.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.4 | 5.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 1.7 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.3 | 0.7 | GO:0055087 | Ski complex(GO:0055087) |
0.3 | 1.0 | GO:0000802 | transverse filament(GO:0000802) |
0.3 | 1.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.3 | 0.7 | GO:0032590 | dendrite membrane(GO:0032590) |
0.3 | 10.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 0.8 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.3 | 1.6 | GO:0000801 | central element(GO:0000801) |
0.3 | 0.8 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 0.7 | GO:0030689 | Noc complex(GO:0030689) |
0.2 | 1.8 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 0.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 58.7 | GO:0045202 | synapse(GO:0045202) |
0.2 | 1.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.8 | GO:1990745 | EARP complex(GO:1990745) |
0.2 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 1.8 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.2 | 0.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.2 | 0.5 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 0.7 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 0.2 | GO:0005687 | U4 snRNP(GO:0005687) |
0.2 | 1.0 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 0.2 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.2 | 1.6 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.2 | 1.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 0.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 1.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.6 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 1.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.8 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 1.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.3 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.2 | GO:0000235 | astral microtubule(GO:0000235) |
0.0 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 6.6 | GO:0043005 | neuron projection(GO:0043005) |
0.0 | 0.2 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
22.2 | 44.5 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
19.1 | 57.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
18.3 | 55.0 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
11.2 | 67.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
9.1 | 45.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
8.3 | 24.8 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
8.2 | 41.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
6.8 | 20.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
6.6 | 46.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
6.5 | 19.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
6.5 | 19.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
6.4 | 32.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
6.4 | 38.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
6.4 | 6.4 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
6.2 | 43.3 | GO:0003680 | AT DNA binding(GO:0003680) |
5.4 | 65.2 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
5.2 | 10.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
5.1 | 30.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
4.9 | 19.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
4.8 | 14.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
4.7 | 14.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
4.4 | 26.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
4.3 | 4.3 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
4.2 | 25.5 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
4.2 | 8.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
4.2 | 8.3 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
4.2 | 20.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
4.1 | 12.3 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
4.1 | 16.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
4.0 | 76.5 | GO:0016917 | GABA receptor activity(GO:0016917) |
3.8 | 11.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
3.8 | 15.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
3.7 | 29.8 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
3.7 | 3.7 | GO:0003896 | DNA primase activity(GO:0003896) |
3.7 | 18.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
3.5 | 70.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
3.4 | 27.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
3.4 | 6.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
3.3 | 13.4 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
3.3 | 13.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
3.2 | 12.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
3.2 | 9.7 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
3.2 | 9.7 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
3.2 | 12.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
3.2 | 15.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
3.1 | 12.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
3.0 | 11.9 | GO:0004065 | arylsulfatase activity(GO:0004065) |
3.0 | 14.9 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
2.9 | 8.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
2.9 | 8.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
2.9 | 2.9 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
2.8 | 11.4 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
2.8 | 8.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
2.7 | 8.2 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
2.7 | 8.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
2.7 | 10.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
2.7 | 24.0 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
2.6 | 26.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
2.6 | 2.6 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
2.6 | 2.6 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
2.6 | 7.8 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
2.5 | 15.2 | GO:0048495 | Roundabout binding(GO:0048495) |
2.5 | 10.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
2.5 | 20.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
2.5 | 4.9 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
2.4 | 16.7 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
2.4 | 11.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
2.4 | 14.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
2.3 | 67.2 | GO:0030507 | spectrin binding(GO:0030507) |
2.3 | 18.3 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
2.3 | 11.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
2.2 | 8.9 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
2.2 | 4.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
2.2 | 4.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
2.1 | 45.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
2.1 | 17.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
2.1 | 12.5 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
2.1 | 22.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
2.1 | 45.3 | GO:0044688 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
2.0 | 6.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
2.0 | 6.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
2.0 | 10.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
2.0 | 9.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
2.0 | 6.0 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
2.0 | 7.9 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
2.0 | 2.0 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
1.9 | 9.7 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.9 | 7.7 | GO:0004849 | uridine kinase activity(GO:0004849) |
1.9 | 30.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.9 | 7.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.9 | 9.4 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
1.9 | 9.4 | GO:0017040 | ceramidase activity(GO:0017040) |
1.9 | 5.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.8 | 16.6 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.8 | 7.3 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.8 | 12.7 | GO:0031628 | opioid receptor binding(GO:0031628) |
1.8 | 37.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.8 | 9.0 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
1.8 | 14.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.8 | 1.8 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
1.8 | 5.3 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.8 | 8.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.8 | 10.6 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
1.7 | 3.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.7 | 3.5 | GO:0097016 | L27 domain binding(GO:0097016) |
1.7 | 3.5 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.7 | 13.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
1.7 | 1.7 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
1.7 | 5.0 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.7 | 13.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
1.6 | 4.8 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
1.6 | 50.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.6 | 22.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.6 | 1.6 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.5 | 23.1 | GO:0031402 | sodium ion binding(GO:0031402) |
1.5 | 6.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
1.5 | 3.0 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
1.5 | 11.7 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
1.5 | 16.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
1.4 | 4.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
1.4 | 12.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.4 | 4.3 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.4 | 5.7 | GO:0070878 | primary miRNA binding(GO:0070878) |
1.4 | 10.0 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
1.4 | 5.7 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
1.4 | 4.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.4 | 4.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.4 | 8.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.4 | 8.2 | GO:0002054 | nucleobase binding(GO:0002054) |
1.3 | 9.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
1.3 | 5.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.3 | 9.0 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
1.3 | 12.7 | GO:0051378 | serotonin binding(GO:0051378) |
1.3 | 7.5 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
1.2 | 14.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
1.2 | 27.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
1.2 | 16.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
1.2 | 3.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.2 | 16.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
1.2 | 4.6 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.1 | 1.1 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
1.1 | 31.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
1.1 | 3.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.1 | 5.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.1 | 3.4 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.1 | 2.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
1.1 | 17.8 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
1.1 | 15.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
1.1 | 5.5 | GO:1990254 | keratin filament binding(GO:1990254) |
1.1 | 7.4 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
1.1 | 2.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
1.0 | 3.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
1.0 | 5.9 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
1.0 | 2.9 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
1.0 | 4.8 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
1.0 | 18.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.9 | 11.3 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.9 | 1.9 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.9 | 7.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.9 | 3.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.9 | 18.2 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.9 | 3.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.9 | 3.6 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.9 | 3.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.9 | 6.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.9 | 3.5 | GO:0019808 | polyamine binding(GO:0019808) |
0.9 | 6.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.9 | 0.9 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.9 | 10.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.9 | 2.6 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.9 | 0.9 | GO:0038191 | neuropilin binding(GO:0038191) |
0.9 | 2.6 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.8 | 0.8 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.8 | 6.6 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.8 | 3.2 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.8 | 18.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.8 | 4.8 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.8 | 4.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.8 | 1.6 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.8 | 7.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.8 | 4.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.8 | 3.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.8 | 5.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.8 | 3.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.8 | 6.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.8 | 21.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.8 | 1.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.8 | 3.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.8 | 2.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.8 | 3.8 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.7 | 2.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.7 | 5.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.7 | 2.2 | GO:0052622 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.7 | 10.0 | GO:0070402 | NADPH binding(GO:0070402) |
0.7 | 0.7 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.7 | 2.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.7 | 2.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.7 | 2.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.7 | 2.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.7 | 1.4 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.7 | 13.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.7 | 15.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.7 | 2.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.7 | 2.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.7 | 2.7 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.7 | 1.3 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.7 | 3.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.6 | 3.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.6 | 5.1 | GO:0015026 | coreceptor activity(GO:0015026) |
0.6 | 1.9 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.6 | 3.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.6 | 3.2 | GO:0016151 | nickel cation binding(GO:0016151) |
0.6 | 2.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.6 | 1.9 | GO:0008948 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) oxaloacetate decarboxylase activity(GO:0008948) |
0.6 | 9.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.6 | 1.9 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.6 | 6.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.6 | 4.3 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.6 | 7.3 | GO:0031005 | filamin binding(GO:0031005) |
0.6 | 6.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.6 | 3.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.6 | 3.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.6 | 1.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.6 | 5.2 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.6 | 0.6 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.6 | 3.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.6 | 5.6 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.6 | 6.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.6 | 3.9 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.6 | 0.6 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.6 | 2.8 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.5 | 1.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.5 | 1.6 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.5 | 2.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.5 | 1.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.5 | 2.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.5 | 11.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.5 | 1.6 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.5 | 3.7 | GO:0033691 | sialic acid binding(GO:0033691) |
0.5 | 1.6 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.5 | 2.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.5 | 11.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.5 | 1.9 | GO:0050693 | LBD domain binding(GO:0050693) |
0.5 | 2.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.5 | 8.5 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.5 | 2.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.5 | 1.4 | GO:0035939 | microsatellite binding(GO:0035939) |
0.5 | 1.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.5 | 9.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.5 | 5.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.4 | 2.7 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.4 | 5.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.4 | 4.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 6.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.4 | 0.9 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.4 | 2.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.4 | 3.8 | GO:0001618 | virus receptor activity(GO:0001618) |
0.4 | 4.6 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.4 | 8.4 | GO:0005537 | mannose binding(GO:0005537) |
0.4 | 4.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.4 | 2.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.4 | 1.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.4 | 1.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 2.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.4 | 2.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.4 | 0.8 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.4 | 4.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.4 | 1.5 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.4 | 0.4 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.4 | 1.1 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.4 | 0.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.4 | 1.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.4 | 1.4 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.4 | 6.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.4 | 12.0 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.3 | 0.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.3 | 1.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.3 | 1.4 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.3 | 2.0 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.3 | 2.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.3 | 2.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.3 | 1.0 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.3 | 1.6 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.3 | 0.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.3 | 3.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 1.0 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.3 | 2.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 6.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.3 | 1.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.3 | 1.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 5.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 0.9 | GO:2001069 | glycogen binding(GO:2001069) |
0.3 | 0.9 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 9.7 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.3 | 0.6 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.3 | 7.4 | GO:0019894 | kinesin binding(GO:0019894) |
0.3 | 0.9 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.3 | 1.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 1.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 1.7 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.3 | 0.6 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.3 | 18.5 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.3 | 3.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 2.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 1.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.3 | 0.8 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 0.3 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.3 | 0.5 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.3 | 2.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 1.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.2 | 5.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 4.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 1.0 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 0.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.2 | 0.7 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 1.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 6.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 0.9 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.2 | 0.7 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 2.6 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 3.0 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 8.3 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.2 | 1.8 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.2 | 3.5 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 1.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.2 | 4.8 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.2 | 1.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 0.6 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 3.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 0.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 0.4 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 1.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 0.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 0.5 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 0.7 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.2 | 0.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 0.7 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 3.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 1.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 0.6 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 0.6 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 0.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 0.8 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 0.6 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 1.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 1.9 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.7 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 1.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 3.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.7 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.1 | 0.5 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 1.0 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 4.2 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.4 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.5 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.8 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 1.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 4.7 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 0.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 1.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.4 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.3 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 2.9 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.4 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.1 | 0.6 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 2.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 14.4 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 14.9 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.0 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.0 | 0.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.1 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.1 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.4 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.0 | 0.3 | GO:0070888 | E-box binding(GO:0070888) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.1 | 5.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
3.6 | 3.6 | ST ADRENERGIC | Adrenergic Pathway |
3.6 | 114.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
2.1 | 31.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.9 | 25.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.9 | 45.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.4 | 12.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.3 | 1.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.2 | 25.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
1.2 | 27.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.8 | 14.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.8 | 2.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.8 | 23.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.7 | 27.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.6 | 19.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.6 | 18.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.5 | 2.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.5 | 8.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.5 | 1.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.5 | 4.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.4 | 0.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.4 | 3.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.4 | 4.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.4 | 0.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.4 | 6.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 4.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 0.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.3 | 6.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 3.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 1.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 1.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 4.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 0.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.6 | 5.6 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
5.1 | 50.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
4.3 | 59.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
4.2 | 46.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
4.1 | 45.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
3.9 | 46.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
3.8 | 38.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
3.5 | 74.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
3.2 | 22.5 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
3.0 | 45.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
2.8 | 5.6 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
2.6 | 21.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
2.6 | 91.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
2.5 | 35.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
2.5 | 39.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
2.4 | 38.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
2.3 | 7.0 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
2.3 | 18.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
2.3 | 49.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
2.2 | 28.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
2.0 | 2.0 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
2.0 | 26.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.8 | 37.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.8 | 32.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
1.8 | 1.8 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
1.8 | 1.8 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
1.7 | 40.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
1.6 | 64.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.5 | 23.2 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
1.5 | 12.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
1.5 | 22.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
1.5 | 10.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
1.4 | 11.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
1.4 | 26.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
1.4 | 18.9 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
1.3 | 26.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
1.3 | 13.1 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
1.3 | 11.6 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
1.2 | 35.6 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
1.2 | 8.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
1.1 | 2.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.1 | 2.2 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
1.0 | 13.3 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
1.0 | 19.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.0 | 3.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.0 | 2.9 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.9 | 17.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.9 | 11.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.9 | 3.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.9 | 7.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.8 | 11.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.8 | 25.6 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.8 | 8.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.7 | 7.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.7 | 2.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.7 | 3.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.7 | 3.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.6 | 4.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.6 | 11.6 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.6 | 10.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.6 | 0.6 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.6 | 1.7 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.6 | 4.4 | REACTOME OPSINS | Genes involved in Opsins |
0.5 | 5.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.5 | 2.1 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.5 | 0.5 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.5 | 1.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.5 | 6.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.5 | 3.6 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.5 | 4.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.4 | 1.8 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.4 | 5.0 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.4 | 0.8 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.4 | 0.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.4 | 2.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.4 | 5.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.4 | 3.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.4 | 4.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 0.6 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.3 | 3.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.3 | 7.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.3 | 3.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 0.8 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.3 | 1.9 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.3 | 1.5 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.3 | 1.0 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.2 | 3.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.2 | 2.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 3.5 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.2 | 0.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 6.1 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.2 | 2.8 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.2 | 3.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 0.2 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.2 | 3.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 1.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 1.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 5.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 1.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 1.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 1.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 2.1 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.1 | 7.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |